virus covid-19 information vaccine

Tonix and Southern Research to study immune responses to Covid-19

Reading now: 436
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Tonix Pharmaceuticals has expanded its ongoing partnership with non-profit Southern Research to study T-cell immune responses to SARS-CoV-2, the novel coronavirus that causes Covid-19.

The partners formed an alliance in March this year to develop a vaccine against Covid-19 using Tonix’s horsepox vaccine platform.

They agreed to develop and conduct animal testing of TNX-1800, a live modified horsepox virus vaccine formulated for percutaneous administration.

As part of the expanded collaboration, the partners aim to generate a blueprint of the human immune system’s response to Covid-19 by analysing samples from who have recovered.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA